全文获取类型
收费全文 | 1247篇 |
免费 | 48篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 11篇 |
妇产科学 | 94篇 |
基础医学 | 131篇 |
口腔科学 | 22篇 |
临床医学 | 119篇 |
内科学 | 266篇 |
皮肤病学 | 17篇 |
神经病学 | 53篇 |
特种医学 | 79篇 |
外科学 | 253篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 55篇 |
眼科学 | 8篇 |
药学 | 43篇 |
肿瘤学 | 124篇 |
出版年
2023年 | 8篇 |
2022年 | 20篇 |
2021年 | 25篇 |
2020年 | 15篇 |
2019年 | 41篇 |
2018年 | 41篇 |
2017年 | 18篇 |
2016年 | 24篇 |
2015年 | 29篇 |
2014年 | 51篇 |
2013年 | 65篇 |
2012年 | 79篇 |
2011年 | 85篇 |
2010年 | 62篇 |
2009年 | 70篇 |
2008年 | 79篇 |
2007年 | 72篇 |
2006年 | 99篇 |
2005年 | 65篇 |
2004年 | 55篇 |
2003年 | 43篇 |
2002年 | 64篇 |
2001年 | 29篇 |
2000年 | 36篇 |
1999年 | 18篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 2篇 |
1992年 | 7篇 |
1991年 | 11篇 |
1990年 | 11篇 |
1989年 | 4篇 |
1986年 | 5篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1975年 | 1篇 |
1971年 | 1篇 |
1962年 | 1篇 |
1943年 | 1篇 |
1941年 | 1篇 |
排序方式: 共有1302条查询结果,搜索用时 11 毫秒
101.
102.
Charisios Karanikiotis Michail Daniilidis Nikolaos Karyotis Charalambos Bakogiannis Theofanis Economopoulos Samuel Murray Demetris Papamichael Epaminondas Samantas Angelos Nikolaou Lemonia Skoura Nikolaos Tselis Nikolaos Zamboglou George Fountzilas MD 《Strahlentherapie und Onkologie》2008,184(6):325-331
BACKGROUND AND PURPOSE: Nasopharyngeal carcinoma (NPC) represents a seldom malignancy in most developed countries. Nevertheless, NPC receives an endemic form in concrete racial entities. The aims of this study were to detect the presence of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood of NPC patients, to molecularly define human leukocyte antigens (HLA) DRB1*, DQA1* and DQB1* allele frequencies, and, finally, to determine whether the genetic predisposition of an individual to NPC depends on the liability to EBV infection. PATIENTS AND METHODS: A total of 101 patients of Hellenic origin and nationality, with histologically proven NPC, participated in this study. EBV-DNA detection was also applied in 66 patients with EBV-related malignancies (Hodgkin's [HL] and non-Hodgkin's lymphoma [NHL]) and infectious mononucleosis (IM), as well as in 80 healthy EBV-seropositive controls. RESULTS: 81% of the NPC patients, 77.8% with HL, 72.2% with NHL, and 66.7% with IM were EBV-DNA positive, whereas the EBV genome was detected only in 15% of the healthy controls. These differences were statistically significant in all cases. Analysis of HLA class II antigens showed decreased frequency of the DRB1*07 (p = 0.003), DQA1*0103 (p = 0.002), and DQA1*0201 (p = 0.003) alleles among NPC patients. A significant association between the HLA-DR/DQ alleles and the presence of EBV-DNA in peripheral whole blood was not established. CONCLUSION: Circulating EBV-DNA and specific HLA class II alleles may predispose to or protect from NPC. However, the results of this study suggest that the genetic predisposition of an individual to NPC is independent of the liability to EBV infection. 相似文献
103.
104.
D. Giakoustidis K. Diplaris N. Antoniadis A. Papagianis N. Ouzounidis I. Fouzas D. Vrochides D. Kardasis G. Tsoulfas A. Giakoustidis G. Miserlis G. Imvrios V. Papanikolaou D. Takoudas 《Transplantation proceedings》2008,40(9):3173-3175
We retrospectively evaluated the use of double-j stent and the incidence of urological complications in 2 groups of patients who received a kidney transplant. From January 2005 to September 2007 we studied 172 patients receiving kidney transplants, 65 and 107 from living and cadaver donors, respectively. From the 172 patients, a total of 34 were excluded due to ureterostomy or Politano-Leadbetter ureterovesical anastomosis. Another 21 patients were excluded from the study due to graft loss due to acute or hyperacute rejection, cytomegalovirus (CMV) infection, or vascular complication. The remaining patients were divided into 2 groups: group A (44 patients) and B (73 patients) with versus without the use of a double-j-stent, respectively. The 2 groups were comparable in terms of donor and recipient gender, ischemia time, and delayed graft function. We failed to observes significant differences between the 2 groups in mean hospital stay (23 ± 9 and 19 ± 9), urinary leak (2.3% and 4.1%), and urinary tract infection (20.4% and 19.2%), among groups A and B, respectively. The only difference observed concerned the gravity of the urinary leak; no surgical intervention was needed among the double-j stent group versus 2 patients demanding ureterovesical reconstruction in the nonstent group. In conclusion, our data suggested that the routine use of a double-j stent for ureterovesical anastomosis neither significantly increased urinary tract infection rates, nor decreased the incidence of urinary leaks, but may decrease the gravity of the latter as evidenced by the need for surgical intervention. 相似文献
105.
106.
107.
3H-Clonidine and 3H-yohimbine were observed to bind to glass fiber filters. The binding was displaced by co-filtration with the corresponding non-radioactive ligand. Phentolamine and (–)-norepinephrine were ineffective in displacing either 3H-clonidine or 3H-yohimbine bound to filters. Failure to correct for filter binding resulted in an over-estimation of specific binding to platelet membranes. Certain published methodologies may have consequently misidentified up to 20% of the specific binding to platelets, that was actually due to displaced filter binding. Experimental conditions are described which eliminate filter binding. These results are significant for the interpretation of data from studies of platelet binding in depressed patients.
Offprint requests to: J.E. Piletz 相似文献
108.
109.
Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion 总被引:1,自引:0,他引:1
Katsoulidou AS Moschidis ZM Gialeraki RE Paraskevis DN Sypsa VA Lazanas MC Tassopoulos NC Psichogiou MA Boletis JN Karafoulidou AS Hatzakis AE 《Transfusion》2004,44(1):59-66
BACKGROUND: One HIV-1 and HCV assay simultaneously detects HIV-1 and HCV RNA (Procleix, Chiron Corp.). The main intended use of the assay is the testing of blood and blood products in blood banking. STUDY DESIGN AND METHODS: To evaluate the clinical sensitivity of the assay, 164 anti-HIV-1+ and 160 anti-HCV+ patients of different viral load were tested. The assay specificity was determined in 1000 HIV-1- and HCV-seronegative blood donors. The ability of the assay to detect different HCV genotypes was investigated in a total of 40 patients of different genotypes (1-4). Furthermore, to investigate the reduction of the HCV window phase before seroconversion, serial samples of 25 hemodialysis patients who seroconverted to anti-HCV were also tested. RESULTS: The assay detected all 60 HIV-1-infected patients with a viral load of greater than 50 copies per mL and 48 of 104 patients with a viral load of less than 50 copies per mL. Moreover, all 60 patients with an HCV RNA load of greater than 521 IU per mL and 7 of 100 patients with a viral load of less than 50 IU per mL tested positive. The assay specificity was found to be 100 percent. In addition, all 40 patients of different HCV genotypes were successfully detected. Finally, the median time that the assay detected HCV infection before second- and third-generation anti-HCV assay was found to be 183 and 91 days, respectively. CONCLUSION: The assay sensitivity and specificity, its ability to detect different HCV genotypes, and the significant reduction of window period of HCV infection further support its use for improving the safety of blood and blood products. 相似文献
110.
Stephan Ehrmann Ferran Roche-Campo Laetitia Bodet-Contentin Keyvan Razazi Jonathan Dugernier Josep Trenado-Alvarez Alexis Donzeau François Vermeulen David Thévoz Metaxia Papanikolaou Antoine Edelson Héctor León Yoshido Lise Piquilloud Karim Lakhal Carlos Lopes Carlos Vicent Arnaud Desachy Gabriela Apiou-Sbirlea Daniel Isabey Laurent Brochard Reva Research Network AT@ICU Study Group 《Intensive care medicine》2016,42(2):192-201